Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

2 stocks I’d buy over Rolls-Royce

Right now, UK investors are piling into Rolls-Royce shares. Edward Sheldon isn’t convinced that’s a good idea. Here are two stocks he’d buy instead.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK investors continue to pile into Rolls-Royce shares. Last week, Rolls-Royce was one of the most purchased stocks on a number of major investment platforms.

While its share price could potentially rise from here as the travel industry rebounds, I won’t be buying the stock. The reason? The FTSE 100 company has a very poor record when it comes to generating long-term shareholder wealth. Over the years, it’s disappointed investors on many occasions.

There are plenty of other UK shares I’d buy today however. Here’s a look at two.

This FTSE 100 company is flying under the radar

One FTSE 100 stock I like the look of right now is Hikma Pharmaceuticals (LSE: HIK). It’s an under-the-radar healthcare company that manufactures generic, branded, and injectable medicines.

Hikma has a much stronger track record than Rolls-Royce when it comes to generating long-term growth. While Rolls-Royce’s revenue went backwards between 2015 and 2020, Hikma’s top line surged 63%.

There’s more to Hikma than just revenue growth however. This company’s quite profitable and has a good dividend growth track record. Last year, it increased its payout from $0.44 per share to $0.50 per share (Rolls-Royce paid no dividend).

Of course, Hikma isn’t perfect. Like every company, it’s had setbacks in the past. In 2017, for example, it generated a loss on the back of challenging market conditions and some issues with the US Food and Drug Administration (FDA). It could experience similar issues in the future.

Overall however, I see a lot to like about Hikma. At its current valuation (forward-looking P/E of 19.6), I think the stock’s worth buying. 

A very profitable company

Another UK share I’d buy over Rolls-Royce is Rightmove (LSE: RMV). It operates the UK’s largest property website.

Rightmove also has a very good track record when it comes to generating long-term growth. Between 2015 and 2019, revenue climbed from £192.1m to £289.3m. Revenue did take a hit last year during the pandemic (£205.7m), but it’s expected to bounce back this year. Currently, analysts forecast revenue of £295.2m for 2021.

One thing that stands out about Rightmove is that it’s extremely profitable. Over the last three years, return on capital employed (ROCE) has averaged 427% (versus -7% for Rolls-Royce). Companies that generate a very high ROCE tend to be good long-term investments.

As Warren Buffett’s business partner Charlie Munger says: “If the business earns six percent on capital over forty years and you hold it for that forty years, you’re not going to make much different than a six percent return. Conversely, if a business earns eighteen percent on capital over twenty or thirty years, even if you pay an expensive looking price, you’ll end up with one hell of a result.”

A risk to consider is rising competition. Companies such as Zoopla and OnTheMarket are trying to grab market share. However, they’ve a long way to go to topple Rightmove. Last year, its market share of the top four property portals was 87.8%.

Rightmove shares aren’t cheap. Currently, the stock trades on a forward-looking P/E ratio of about 32. I think RMV is worth the premium though. At its current valuation, I see it as a ‘buy’.

Edward Sheldon owns shares of Rightmove. The Motley Fool UK has recommended Hikma Pharmaceuticals and Rightmove. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Lady taking a carton of Ben & Jerry's ice cream from a supermarket's freezer
Investing Articles

Should I scoop up some Magnum Ice Cream shares for my ISA? 

The world's largest ice cream business started trading on the London Stock Exchange today. Is this the next buy for…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

2 incredible FTSE 100 shares I can’t stop buying!

Discover the two FTSE 100 shares our writer Royston Wild's been piling into -- and why he expects them to…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing For Beginners

This FTSE 100 share has a P/E ratio less than half the index average! Is it a bargain buy?

Jon Smith points out a FTSE 100 share with a P/E ratio of just 7.37, as he continues his hunt…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Why this FTSE banking gem may hold a lot more value than we think

This FTSE banking giant may be hiding more value than investors expect -- with rising dividends, buybacks, and growth potential…

Read more »

Tesla building with tesla logo and two teslas in front
US Stock

I asked ChatGPT where Tesla stock will be in a year’s time and this is what it said…

Jon Smith got an underwhelming response from ChatGPT regarding Tesla stock's 2026 potential performance, and provides his viewpoint on the…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’ve made this much from 417 shares in this FTSE 100 dividend income gem since 2020…

My £10k investment in this FTSE 100 heavyweight has grown hugely since 2020. With dividends up and the shares still…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Is easyJet a steal at its near-£5 share price after strong 2025 results?

easyJet’s share price has slipped 16% from its peak -- but is this turbulence masking a hidden value gap investors…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can target £7,570 a year in dividend income from £20,000 in this FTSE 250 media gem

This FTSE 250 star looks very undervalued, but with a 6%+ dividend yield investors could lock in high passive income…

Read more »